ANVISA registration

PSA Prostate Specific Antigen Semi-Quantitative Ultra Rapid Test Device (Sangue Total/Soro/Plasma)

Registration 10071770842. ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)

Registration details

Registration number10071770842
Application number25351788819201408
Technical nameANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)
Risk classIII
Published on30/03/2015
ValidityValid until 30/11/2035

Registration holder

Legal nameABBOTT DIAGNOSTICOS RAPIDOS S.A.
CNPJ50.248.780/0001-61

Manufacturer

  • ABON BIOPHARM (HANGZHOU) CO LTD CHINA, REPÚBLICA POPULAR

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist